Información:
Error:
ID
34331
Descripción
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.; ODM derived from: https://clinicaltrials.gov/show/NCT01088659
Link
https://clinicaltrials.gov/show/NCT01088659
Palabras clave
Versiones (1)
- 16/1/19 16/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Hepatitis D, Chronic NCT01088659
Eligibility Hepatitis D, Chronic NCT01088659
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis D, Chronic NCT01088659
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
chronic hepatitis d
boolean
ID.3
Item
positive for hbsag >/=6 months, for anti-hdv >/=3 months and for hdv-rna at screening
boolean
ID.4
Item
negative pregnancy test; fertile males and women of childbearing age should use two reliable forms of contraception throughout study
boolean
ID.5
Item
antiviral therapy for chronic hepatitis d within the previous 6 months
boolean
ID.6
Item
previous therapy with pegylated interferon alfa
boolean
ID.7
Item
treatment with conventional interferon alfa for >12 months
boolean
ID.8
Item
hepatitis a or c, or hiv infection
boolean
ID.9
Item
decompensated liver disease (childs b-c)
boolean
ID.10
Item
history or evidence of medical condition associated with chronic liver disease
boolean